source
- FDA approves Viridian's Lumvoa, positioning it against Amgen's Tepezza in thyroid eye diseaseThe Food and Drug Administration has granted approval for Viridian Therapeutics' drug Lumvoa to treat thyroid eye disease, an autoimmune condition that can cause eye pain, bulging and vision proble…
- Beeline Medicines raises $126.3M, bringing total Series A funding to $426.3M for immune‑drug developmentBeeline Medicines announced an additional $126.3 million in Series A financing, pushing the total raised to $426.3 million. The capital boost was disclosed on Tuesday and follows an earlier spring…